Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug may hinder recovery from heart attacks

11.11.2004


Some new generation COX-2 inhibitors may not allow heart attack patients to recover fully, research indicates.



Researchers at the University of Alberta have discovered a basic cellular process the body uses to balance pH in cells--also critical to recovery following a heart attack--is compromised by certain novel COX-2 inhibitors.

Bicarbonate transporters, enzymes critical to maintaining this delicate balance of bicarbonate across the cell membrane, are potently inhibited from doing their work by some clinically used non-steroidal anti-inflammatory drugs such as celecoxib, the active ingredient in Celebrex.


Celecoxib is an effective anti-inflammatory drug because of its effects on the enzyme cyclooxygenase-2 (COX-2). The work from the Casey laboratory indicates that the reported side-effects of celecoxib may result from their unintended inhibition of the body’s ability to move bicarbonate. The work was headed up by principal researcher Joe Casey, a University of Alberta physiology professor.

Bicarbonate (HCO3-) is the primary pH buffer of our bodies and the primary waste product of cellular energy production. Movement of the base, HCO3-, into or out of a cell will alkalinize or acidify the cell. Our cells carefully control the concentration and movement of HCO3- across the plasma membrane by regulation of bicarbonate transport proteins (BT) that can rapidly catalyse the transmembrane movement of HCO3-. The focus of Dr. Casey’s laboratory’s research is to understand the processes of transmembrane HCO3- transport at the molecular and cellular levels.

The work will appear in the November 23 issue of Molecular Membrane Biology. Co-researchers included Patricio Morgan, a postdoctoral research fellow in the Casey Research Group, and Claudiu Supuran, of the University of Florence, Dipartimento di Chimica, Laboratorio di Chimica Bioinorganica,Sesto Fiorentino, Italy.

Dr. Casey’s work is funded by the Canadian Institutes of Health Research and the Heart and Stroke Foundation. Dr. Casey is a Senior Scholar of the Alberta Heritage Foundation for Medical Research.

Michael Robb | EurekAlert!
Further information:
http://www.ualberta.ca

More articles from Life Sciences:

nachricht Navigational view of the brain thanks to powerful X-rays
18.10.2017 | Georgia Institute of Technology

nachricht Separating methane and CO2 will become more efficient
18.10.2017 | KU Leuven

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>